United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Sep 15, 2026 · Filed Sep 16, 2026

On Sep 15, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$501.59 for US$4.77M under a trading plan, leaving 324,443 shares. Filed Sep 16, 2026 (Form 4).

Sold
9,500 shares
Price
US$501.59 average (US$499.77 to US$504.57)
Value
US$4.77M
Holding after
324,443 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 15, 2026Common StockOption exercise9,500US$117.76333,943Indirect
Sep 15, 2026Common StockSale780US$499.77333,163Indirect
Sep 15, 2026Common StockSale3,711US$500.68329,452Indirect
Sep 15, 2026Common StockSale2,689US$501.66326,763Indirect
Sep 15, 2026Common StockSale825US$502.57325,938Indirect
Sep 15, 2026Common StockSale845US$503.80325,093Indirect
Sep 15, 2026Common StockSale650US$504.57324,443Indirect

Source

View original at SEC

Related